IL-33 orchestrates tissue remodeling and immune response in chronic airway inflammation through both TH2 (initiated by ILC2 matured by IL-33) and TH17 (via IL-1β and IL-6 derived from IL-33-matured DCs) immune responses [40]. The gene discussed is IL33; the disease is inflammatory response.